ARCHIVES

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

Toxicology Program Seeks Comment On Substances.

March 23, 2001

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

July 20, 1979

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011

Review Of NCI Intramural Program Offers Over 60 Recommendations For Change

July 7, 1995

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

April 25, 2014